Andrea Bezjak

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +15

Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

Christina A. Meyers, Jennifer A. Smith, Andrea Bezjak et al. · Journal of Clinical Oncology · 2003 · 587 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre‐Finn, M. Snee, Linda Ashcroft et al. · The Lancet Oncology · 2017 · 570 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

Andrea Bezjak, Rebecca Paulus, Laurie E. Gaspar et al. · Journal of Clinical Oncology · 2019 · 548 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases

Minesh P. Mehta, Patrick Rodrigus, C. Terhaard et al. · Journal of Clinical Oncology · 2003 · 464 citations

Medicine, Oncology, Radiation Oncology +17